Skip to content

Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults

Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05182190
Enrollment
18
Registered
2022-01-10
Start date
2019-07-10
Completion date
2020-03-15
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose, High Blood

Keywords

glucose, insulin, legumes

Brief summary

The study purpose is to determine the effect of eating three (3) different pasta flour formulations made from 100% black beans (Zenith) in a meal matrix (spaghetti sauce) on postprandial glycemic response in healthy adults.

Detailed description

The 5 test treatments (white bread (negative control), whole black beans (positive control), and 3 different pasta formulations) will be administered randomly over five weeks. Meals will be combined with spaghetti sauce for a total available carbohydrate amount of 50g. Venous blood samples will be collected for glucose and insulin analysis at time 0 (fasting) and at 30, 60, 90, 120, and 180 minutes post-treatment (timing of the post-treatment blood draws started at time 0 \[post-treatment\], which is when the participant starts consuming the treatment meal). Blood analysis was completed by a reputable biomarker diagnostics laboratory, Quest Diagnostics. Anthropometric measures such as weight, height, waist circumference, and blood pressure were collected at screening and at the start of each test day. Thirteen hours before testing, participants consumed a standardized frozen meal to reduce the potential variation in glycemic responses on test day due to varying pre-evening dietary intakes. This control meal was selected by each participant before the start of the study. Each participant was provided the same frozen meal every time, since the subjects serve as their own controls. The day before test day, participants completed a 24 hour food recall, satiety, and gastrointestinal questionnaires. The morning of each test day participants completed the International Physical Activity Questionnaire (IPAQ), satiety, and gastrointestinal questionnaires.

Interventions

DIETARY_SUPPLEMENTWhite bread

Toasted white bread

DIETARY_SUPPLEMENTBlack beans whole boiled

Whole boiled black beans with spaghetti sauce

DIETARY_SUPPLEMENTKnife Mill pasta

Black bean pasta (KM) with spaghetti sauce

DIETARY_SUPPLEMENTCombo Flour Pasta

Black bean pasta (Combo) with spaghetti sauce (medium protein flour)

DIETARY_SUPPLEMENTCyclone Flour Pasta

Black bean pasta (Cyclone) with spaghetti sauce (low protein flour)

Sponsors

USDA Beltsville Human Nutrition Research Center
CollaboratorFED
Iowa State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

5 x 5 crossover study with 3 treatments and two controls

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* normal blood glucose * BMI between 20-29.9 kg/m2. * Chronic health conditions, e.g., hypertension, gastrointestinal disease.

Exclusion criteria

* Weight changes of \>10% of body weight within previous 6 months * Pregnant or breastfeeding * Allergy to peas, beans, lentils, tomatoes, gluten, or latex * Unwillingness or inability to follow study protocol

Design outcomes

Primary

MeasureTime frameDescription
Change in baseline blood glucose over 3 hours (glycemic response)Time 0 (fasting) then every 30 minutes for 3 hoursVenous blood samples were collected via venous catheter. Whole blood samples were analyzed for glucose content and insulin at commercial laboratory.

Secondary

MeasureTime frameDescription
Change in satiety sensationTime 0 (fasting) then every 30 minutes for 3 hoursSatiety level measured using a visual analog scale (0-100) every 30 minutes postprandially. A higher score indicates greater satiety.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026